EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma
出版年份 2015 全文链接
标题
EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma
作者
关键词
-
出版物
PLoS One
Volume 10, Issue 2, Pages e0117493
出版商
Public Library of Science (PLoS)
发表日期
2015-02-07
DOI
10.1371/journal.pone.0117493
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Loss of 4E-BP1 function induces EMT and promotes cancer cell migration and invasion via cap-dependent translational activation of snail
- (2015) Weijia Cai et al. Oncotarget
- MNK1 pathway activity maintains protein synthesis in rapalog-treated gliomas
- (2014) Michal Grzmil et al. JOURNAL OF CLINICAL INVESTIGATION
- eRF3b, a Biomarker for Hepatocellular Carcinoma, Influences Cell Cycle and Phosphoralation Status of 4E-BP1
- (2014) Man Li et al. PLoS One
- eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation
- (2014) Rita Spilka et al. CELLULAR ONCOLOGY
- Many roads from mTOR to eIF4F
- (2013) Carson C. Thoreen BIOCHEMICAL SOCIETY TRANSACTIONS
- Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment
- (2013) Tuomas Heikkinen et al. BREAST CANCER RESEARCH AND TREATMENT
- Eukaryotic translation initiation factors in cancer development and progression
- (2013) Rita Spilka et al. CANCER LETTERS
- Functional crosstalk between AKT/mTOR and Ras/MAPK pathways in hepatocarcinogenesis: Implications for the treatment of human liver cancer
- (2013) Chunmei Wang et al. CELL CYCLE
- Overexpression of 4EBP1, p70S6K, Akt1 or Akt2 differentially promotes Coxsackievirus B3-induced apoptosis in HeLa cells
- (2013) X Li et al. Cell Death & Disease
- Anti-oncogenic potential of the eIF4E-binding proteins
- (2012) Y Martineau et al. ONCOGENE
- Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response
- (2012) Rita Spilka et al. Journal of Oncology
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1
- (2011) Elin Karlsson et al. GENES CHROMOSOMES & CANCER
- Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer
- (2011) Jae Hong No et al. GYNECOLOGIC ONCOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells
- (2010) Qinjie Weng et al. INVESTIGATIONAL NEW DRUGS
- Cancer gene discovery in hepatocellular carcinoma
- (2010) Lars Zender et al. JOURNAL OF HEPATOLOGY
- Human cytomegalovirus UL69 protein facilitates translation by associating with the mRNA cap-binding complex and excluding 4EBP1
- (2010) M. Aoyagi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started